About this trial
It has been proved that lithium carbonate can prolong slow wave sleep with few or no side-effects. The aim of the present study is to evaluate postoperative sleep quality of patients undergoing heart valve surgery with cardiopulmonary bypass taken 250mg lithium carbonate after surgery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ethnic Chinese;
Age, 18 to 65 years old;
Patients undergoing heart valve surgery with cardiopulmonary bypass
Disqualifiers
Preoperative Pittsburgh Sleep Quality Index global scores higher than 6
Cognitive difficulties
Partial or complete gastrectomy
Previous esophageal surgery
Trial design
Parallel
Treatments tested in this trial
Lithium Carbonate 250 MG Oral Tablet
DrugPatients undergoing heart valve surgery withcardiopulmonary bypass will take 250mg lithium carbonate
Calcium Carbonate 500 MG Oral Tablet
DrugPatients undergoing heart valve surgery withcardiopulmonary bypass will take 500mg calcium carbonate
Treatment groups
Trial outcomes
Primary outcomes
sleep quality
Duration of sleep was collected with polysomnography on second postoperative night. (from 20:00pm to 06:00am)
Secondary outcomes
serum metabolites
This study will characterize the serum metabolites of patients before and after heart valve surgery
Other outcomes
Cognitive function
Mini-Mental State Examination (MMSE) score was performed
Sponsors and contacts
Click on the lead sponsor to view all of their trials.